EPO and anemia: Furthermore, the overactivation of the Renin–Angiotensin–Aldosterone System (RAAS) plays a crucial role in the progression of both cardiac and renal diseases, contributing to the worsening of anemia through mechanisms such as erythropoietin resistance [11,12].